About Drugs Made In America Acquisition Corp. Rights
https://dmaacorp.comDrugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
CEO
Lynn Stockwell
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Shell Companies
Sector Financial Services
Went public N/A
Full time employees 0
ETFs Holding This Stock
Summary
Total 1
Showing Top 1 of 1
Ratings Snapshot
Rating : C+
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 4
Debt To Equity 1
Price To Earnings 4
Price To Book 1
Overall Score 2
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
Market Cap $3.26 M
52w High $0.15
52w Low $0.15
P/E 0
Volume 2
Outstanding Shares 20.40M
About Drugs Made In America Acquisition Corp. Rights
https://dmaacorp.comDrugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $263.7K ▲ | $2.18M ▼ | 0% | $0.07 ▲ | $0 ▲ |
| Q2-2025 | $0 | $131.92K ▼ | $2.29M ▲ | 0% | $0.07 ▼ | $-131.92K ▲ |
| Q1-2025 | $0 | $330.93K ▲ | $1.25M ▲ | 0% | $130.51 ▲ | $-330.93K ▼ |
| Q4-2024 | $0 | $279.88 ▼ | $-279 ▲ | 0% | $-0.03 ▼ | $0 ▲ |
| Q3-2024 | $0 | $144.93K | $-144.93K | 0% | $-0.01 | $-144.93K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $717 ▼ | $237.63M ▲ | $7.36M ▲ | $-7.33M ▼ |
| Q2-2025 | $822 ▼ | $235.21M ▲ | $7.2M ▼ | $228M ▲ |
| Q1-2025 | $923 ▼ | $232.81M ▲ | $7.25M ▲ | $225.56M ▲ |
| Q4-2024 | $1.35K ▼ | $550.82 ▼ | $795.67 ▼ | $-244 ▲ |
| Q3-2024 | $2.1K | $426.14K | $591K | $-164.86K |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $785.09K ▼ | $137.91K ▲ | $231.15M ▲ | $-231.3M ▼ | $-105 ▲ | $137.9K ▲ |
| Q2-2025 | $3.69M ▲ | $-300.67K ▼ | $-231.15M | $231.47M ▲ | $-1.27K ▼ | $-300.67K ▼ |
| Q1-2025 | $1.25M ▲ | $-251.24K ▼ | $-231.15M ▼ | $231.4M ▲ | $-428 ▲ | $-251.24K ▼ |
| Q4-2024 | $-279 ▲ | $-106 ▲ | $0 | $-638 ▼ | $-744 ▲ | $-123 ▲ |
| Q3-2024 | $-144.93K | $-57.23K | $0 | $41.23K | $-16K | $-57.23K |
CEO
Lynn Stockwell
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Shell Companies
Sector Financial Services
Went public N/A
Full time employees 0
ETFs Holding This Stock
Summary
Total 1
Showing Top 1 of 1
Ratings Snapshot
Rating : C+
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 4
Debt To Equity 1
Price To Earnings 4
Price To Book 1
Overall Score 2
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0